Dr. John Wofford, MD
What this data tells you about Dr. Wofford
Dr. John Wofford is a dermatopathology physician in Dallas, TX, with 14 years in practice. Based on federal Medicare data, Dr. Wofford performed 18,209 Medicare services across 9,347 unique beneficiaries.
Between the years covered by Open Payments, Dr. Wofford received a total of $10,695 from 40 pharmaceutical and/or device companies across 388 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatopathology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Wofford is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Tissue pathology examination, moderate complexity | 12,305 | $51 | $233 |
| Destruction of precancerous skin growths, 2-14 | 2,042 | $5 | $23 |
| Office visit, established patient (20-29 min) | 681 | $60 | $297 |
| Destruction of precancerous skin growth, 1 | 458 | $36 | $223 |
| Skin biopsy, tangential | 400 | $70 | $338 |
| Pathology examination of tissue using a microscope, moderately low complexity | 397 | $31 | $140 |
| Tissue staining for diagnosis, initial | 353 | $26 | $112 |
| Tissue staining for diagnosis, additional | 307 | $22 | $91 |
| Special stained specimen slides to identify organisms including interpretation and report | 295 | $81 | $357 |
| Biopsy of related skin growth, each additional growth | 232 | $41 | $168 |
| Destruction of skin growths (warts/lesions), 1-14 | 192 | $87 | $378 |
| Office visit, established patient (30-39 min) | 191 | $88 | $420 |
| Destruction of precancer skin growth, 15 or more growths | 91 | $128 | $562 |
| New patient office visit (30-44 min) | 57 | $68 | $369 |
| Office visit, established patient (10-19 min) | 41 | $41 | $186 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 31 | $135 | $594 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 21 | $100 | $813 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 21 | $250 | $1,011 |
| Biopsy of ear | 21 | $52 | $321 |
| Special stained specimen slides to examine tissue including interpretation and report | 20 | $56 | $248 |
| New patient office visit (45-59 min) | 20 | $97 | $547 |
| Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | 18 | $152 | $683 |
| Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | 15 | $131 | $627 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Wofford is a mixed practice specialist, with above-average Medicare volume (top 5% in TX), and high industry engagement (low-engagement, top 16%).
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Wofford experienced with tissue pathology examination, moderate complexity?
Does Dr. Wofford receive payments from pharmaceutical companies?
How do Dr. Wofford's costs compare to other dermatopathology physicians in Dallas?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology